NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:NHC • US6359061008

149.29 USD
+6.18 (+4.32%)
At close: Feb 2, 2026
149.29 USD
0 (0%)
After Hours: 2/2/2026, 8:27:20 PM
Fundamental Rating

6

Taking everything into account, NHC scores 6 out of 10 in our fundamental rating. NHC was compared to 102 industry peers in the Health Care Providers & Services industry. While NHC has a great profitability rating, there are some minor concerns on its financial health. NHC has a valuation in line with the averages, but on the other hand it scores bad on growth. NHC also has an excellent dividend rating. These ratings could make NHC a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NHC was profitable.
  • In the past year NHC had a positive cash flow from operations.
  • Each year in the past 5 years NHC has been profitable.
  • NHC had a positive operating cash flow in each of the past 5 years.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • NHC's Return On Assets of 6.71% is amongst the best of the industry. NHC outperforms 86.27% of its industry peers.
  • NHC has a better Return On Equity (10.26%) than 73.53% of its industry peers.
  • With a decent Return On Invested Capital value of 6.69%, NHC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • NHC had an Average Return On Invested Capital over the past 3 years of 3.68%. This is significantly below the industry average of 9.16%.
  • The last Return On Invested Capital (6.69%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROIC 6.69%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • NHC's Profit Margin of 7.19% is amongst the best of the industry. NHC outperforms 86.27% of its industry peers.
  • NHC's Profit Margin has improved in the last couple of years.
  • NHC has a Operating Margin of 7.99%. This is in the better half of the industry: NHC outperforms 75.49% of its industry peers.
  • NHC's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 38.11%, NHC is doing good in the industry, outperforming 67.65% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
  • NHC has more shares outstanding than it did 1 year ago.
  • NHC has more shares outstanding than it did 5 years ago.
  • NHC has a worse debt/assets ratio than last year.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.61 indicates that NHC is not in any danger for bankruptcy at the moment.
  • NHC's Altman-Z score of 4.61 is amongst the best of the industry. NHC outperforms 80.39% of its industry peers.
  • NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.93, NHC belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
  • NHC has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.10, NHC is doing good in the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Altman-Z 4.61
ROIC/WACC0.75
WACC8.86%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • NHC has a Current Ratio of 1.72. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • NHC's Current ratio of 1.72 is fine compared to the rest of the industry. NHC outperforms 68.63% of its industry peers.
  • NHC has a Quick Ratio of 1.69. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.69, NHC is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.69
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.19% over the past year.
  • NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
  • NHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.82%.
  • NHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.25, the valuation of NHC can be described as rather expensive.
  • NHC's Price/Earnings ratio is a bit cheaper when compared to the industry. NHC is cheaper than 69.61% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.41. NHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.25
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 66.67% of the companies in the same industry are more expensive than NHC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 68.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.48
EV/EBITDA 12.59
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • NHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.77
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.83%, NHC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.47, NHC pays a better dividend. On top of this NHC pays more dividend than 91.18% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, NHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.30%.
  • NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 35.96% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (2/2/2026, 8:27:20 PM)

After market: 149.29 0 (0%)

149.29

+6.18 (+4.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31
Earnings (Next)02-13
Inst Owners62.44%
Inst Owner Change-0.23%
Ins Owners7.07%
Ins Owner Change-0.09%
Market Cap2.32B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.25
Fwd PE N/A
P/S 1.59
P/FCF 19.48
P/OCF 15.54
P/B 2.27
P/tB 2.79
EV/EBITDA 12.59
EPS(TTM)6.71
EY4.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.13%
OCF(TTM)9.61
OCFY6.43%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.77
Graham Number99.7
Profitability
Industry RankSector Rank
ROA 6.71%
ROE 10.26%
ROCE 9.01%
ROIC 6.69%
ROICexc 8.35%
ROICexgc 10.23%
OM 7.99%
PM (TTM) 7.19%
GM 38.11%
FCFM 8.16%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.93
Debt/EBITDA 0.64
Cap/Depr 68.45%
Cap/Sales 2.07%
Interest Coverage 250
Cash Conversion 92.81%
Profit Quality 113.47%
Current Ratio 1.72
Quick Ratio 1.69
Altman-Z 4.61
F-Score4
WACC8.86%
ROIC/WACC0.75
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%

NATIONAL HEALTHCARE CORP / NHC FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.